Eli Lilly Data Demand Sparks Hospital Backlash & 340B Fight
The 340B Program Under Fire: A Looming Data War Between Pharma and Hospitals The recent clash between Eli Lilly and the American Hospital Association (AHA) isn’t just a single dispute; it’s a harbinger of a much larger trend reshaping the pharmaceutical landscape. Lilly’s demand for comprehensive claims data from hospitals participating in the 340B Drug … Read more